Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02183883
Title Deciphering Afatinib Response and Resistance With INtratumour Heterogeneity (DARWIN1)
Acronym DARWIN1
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors University College, London
Indications
Therapies
Age Groups: adult | senior
Covered Countries GBR


No variant requirements are available.